Drugs News and Research

RSS

Caregivers are not choosing low cost plan option, says new study

A new study from Caring.com has revealed at least a third of its members are caring for aging parents or loved ones enrolled in a Medicare Part D prescription drug plan and among this group, only half are aware of how and where to enroll in the program and less than half (40%) are aware of what it covers.

4 Dec 2009

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

Isis Pharmaceuticals, Inc. announced today that it has added two new drugs to its development pipeline, ISIS-FXIRx and ISIS-SMNRx.

4 Dec 2009

Two antimicrobial drug developing companies evaluate new approach for treating bacterial infections

Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.

4 Dec 2009

ISTODAX included in the updated NCCN Clinical Practice Guidelines in Oncology

Gloucester Pharmaceuticals announced today that ISTODAX® (romidepsin) has been included in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ as a suggested systemic treatment option for patients with mycosis fungoides and Sézary syndrome—two of the most common types of cutaneous T-cell lymphoma (CTCL).

4 Dec 2009

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

VirtualScopics, Inc., a leading provider of quantitative imaging for clinical trials, announced today that its patent titled "System and Method for 4D Reconstruction and Visualization" recently received issuance in Japan.

4 Dec 2009

Instacare announces initial parallel marketing strategy for its cell phone centric products

Instacare Corp., a leading provider of life-saving prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs and a leading developer of e-health technology and revolutionary cell phone centric technologies and products announced today its intent to file multiple updated and enhanced patent and trademark applications covering its cell phone centric technologies with the United States Patent and Trademarks Office.

4 Dec 2009

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Research: Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database

4 Dec 2009

Researchers discover new strategy against invasive parasite

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a possible strategy against an invasive parasite that infects more than a quarter of the world's population, including 50 million Americans.

4 Dec 2009

Discovery of antibiotic molecule may lead to the development of potent antibacterial drugs

An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing new, more potent antibacterial drugs.

4 Dec 2009

Senate votes to reject Medicare cuts; Reid discusses next anticipated amendments

The Associated Press reported: "Senators voted 58-42 to reject an amendment by Republican Sen. John McCain of Arizona that would have stripped more than $400 billion in Medicare cuts from the health care bill. The measure would have sent the bill back to the Senate Finance Committee for a redo" (Alonso-Zaldivar, 12/3).

4 Dec 2009

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

3 Dec 2009

American Pain Society supports FDA drug disposal guidelines

Calling it "an important first step in attempting to reverse an escalating public health menace caused by diversion of prescription opioid pain medications," the American Pain Society today announced its support for a new FDA initiative to encourage consumers to remove unused pain drugs from home medicine cabinets.

3 Dec 2009

Report on the type 2 diabetes drug market in Brazil

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the type 2 diabetes drug market in Brazil will grow from $417 million in 2008 to $834 million in 2013.

3 Dec 2009

CBO report shows hundreds of millions spent on direct marketing of drugs to consumers

The Congressional Budget Office released an "interesting report" on on how "pharmaceutical companies market prescription drugs, a subject that has received some scrutiny during the debate on ways to control health care spending," The New York Times reports.

3 Dec 2009

Fruit flies are valid models for studying drug addiction in humans, says scientists

Fruit flies may seem like unlikely heroes in the battle against drug abuse, but new research suggests that these insects - already used to study dozens of human disease - could claim that role. Scientists are reporting that fruit flies can be used as a simpler and more convenient animal model for studying the effects of cocaine and other drugs of abuse on the brain.

3 Dec 2009

FAU professor highlights the need for extensive randomized trials to distinguish drug benefits

In a commentary published in the December 2, 2009 issue of the Journal of the American Medical Association, Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science at Florida Atlantic University, said, "To detect the most likely small to moderate benefits or harm of drugs requires randomized trials of sufficient size and duration. Overreliance on small trials, meta-analyses or subgroup analyses can lead to misleading conclusions."

3 Dec 2009

Financial aspects of cancer treatment reduces compliance

New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient’s battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients’ compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.

3 Dec 2009

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

The Centre for Neglected Tropical Diseases (CNTD) at the Liverpool School of Tropical Medicine has been awarded £10 million by the UK Department for International Development (DFID) to support endemic countries in tackling lymphatic filariasis (LF) - a crippling disease more commonly known as elephantiasis.

3 Dec 2009

Analysis shows fewer victims survive out-of-hospital cardiac arrests

The chance of surviving an out-of-hospital cardiac arrest has not improved since the 1950s, according to a report by the University of Michigan Health System.

3 Dec 2009

PEG polymer may prevent GI injury during cancer radiotherapy

A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage.

3 Dec 2009

Drugs News and Research

Caregivers are not choosing low cost plan option, says new study

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

Two antimicrobial drug developing companies evaluate new approach for treating bacterial infections

ISTODAX included in the updated NCCN Clinical Practice Guidelines in Oncology

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

Instacare announces initial parallel marketing strategy for its cell phone centric products

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Researchers discover new strategy against invasive parasite

Discovery of antibiotic molecule may lead to the development of potent antibacterial drugs

Senate votes to reject Medicare cuts; Reid discusses next anticipated amendments

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

American Pain Society supports FDA drug disposal guidelines

Report on the type 2 diabetes drug market in Brazil

CBO report shows hundreds of millions spent on direct marketing of drugs to consumers

Fruit flies are valid models for studying drug addiction in humans, says scientists

FAU professor highlights the need for extensive randomized trials to distinguish drug benefits

Financial aspects of cancer treatment reduces compliance

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

Analysis shows fewer victims survive out-of-hospital cardiac arrests

PEG polymer may prevent GI injury during cancer radiotherapy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News